North Texas Pharmacy Researchers Awarded CPRIT Funding
The Cancer Prevention & Research Institute of Texas (CPRIT) announced Sept. 14 it was awarding a $2.5 million grant to Richard Leff, Pharm.D.,
and the North Texas Clinical Pharmacology Cancer Core, a group of researchers from
the Texas Tech University Health Sciences Center (TTUHSC) School of Pharmacy campus in Dallas.
Leff, a professor for TTUHSC’s Department of Pharmacy Practice and senior associate dean for the School of Pharmacy’s clinical and translational research, said there is urgent need for translating basic cancer research discoveries into improved care for cancer patients and better interventional tools to cure and prevent cancer. To assist basic cancer researchers and physicians in developing better methods for testing new cancer drugs and cancer treatment therapies that result from these efforts, Leff and a team of TTUHSC School of Pharmacy collaborators have established the North Texas Clinical Pharmacology Cancer Core, a state-of-the-art analytical facility operating in the Dallas Medical District.
“Our team has expertise and state-of-the-art instrumentation to help cancer investigators with designing studies to optimize our understanding of drug movement in the body, the action of drugs and the best approaches to administer the drug and enhance cures while reducing unwanted side effects,” Leff said.
Such testing, Leff added, will assist investigators to better understand how cancer drugs work in the body, how the drugs treat cancer and how to avoid unwanted effects of cancer drugs.
“In general, the research team of this core will support translational researchers to do research on what cancer drugs do to the body and what the human body does to the drugs,” Leff said. “Continued funding will keep the Clinical Pharmacology Cancer Core open and operational, upgrade our laboratory and expand our research capacity and capability to meet clinical pharmacology needs of North Texas cancer investigators.”
The Clinical Pharmacology Cancer Core includes Claudia Meek, Ph.D., Carlos Alvarez, Pharm.D., and Ronald Hall, Pharm.D., from the TTUHSC School of Pharmacy campus in Dallas; and Paul Trippier, Ph.D., from the TTUHSC campus in Amarillo.
Related Stories
38th Student Research Week Successful at Showcasing Secrets of Immune Defense
Student researchers at TTUHSC had the opportunity to showcase their presentation skills at the 38th Annual Student Research Week Feb. 25 – 27.
Celebrating Veterans: TTUHSC’s General Martin Clay’s Legacy of Service and Leadership
From his initial enlistment in the Army National Guard 36 years ago to his leadership in military and civilian health care management roles, Major General Martin Clay’s career has been shaped by adaptability, mission focus and service to others.
Texas Tech University Health Sciences Center School of Nursing Named Best Accelerated Bachelor of Science in Nursing Program in Texas
The TTUHSC School of Nursing Accelerated Bachelor of Science in Nursing (BSN) program has been ranked the No. 1 accelerated nursing program in Texas by RegisteredNursing.org.
Recent Stories
TTUHSC Experts Receive Junior Investigator Research Grants through Texas Alzheimer’s Research and Care Consortium
Texas Tech University Health Sciences Center (TTUHSC) researchers Aric Logsdon, Ph.D., and Jonathan Singer, Ph.D., received Junior Investigator Research Grants from the Texas Alzheimer’s Research and Care Consortium (TARCC).
CPRIT Awards TTUHSC Researcher $1.4 Million Cancer Grant in Efforts to Expand Rural Clinical Trials
The Cancer Prevention and Research Institute of Texas (CPRIT) awarded a $1.4 million grant to Erin Barr, M.D., a clinician of pediatric hematology/oncology and researcher in the School of Medicine at Texas TTUHSC. Barr’s research, “Enhancing access to pediatric oncology clinical trials in West Texas,” received funding under the Recruitment or Retention of Clinical Trialists Award.
Texas Tech University Health Sciences Center’s Klein Selected to Leadership Role by the Texas Pharmacy Association
The Texas Pharmacy Association announced (May 19) the appointment of Mary Klein, Pharm.D., as assistant vice president of Strategic Initiatives and Practice Innovation.